Quality of life in patients with EGFR-mutated lung cancer receiving gefitinib vs gefitinib plus pemetrexed and carboplatin chemotherapy

被引：1
|
作者：
Menon, N. S. [1 ]
Noronha, V. [1 ]
Chowdhury, O. Row [1 ]
Pawar, A. R. [2 ]
Patil, V. M. [1 ]
Singh, A. C. [1 ]
More, S. [1 ]
Goud, S. [1 ]
Yadav, A. [1 ]
Shah, M. J. [3 ]
Jobanputra, K. N. [1 ]
Shah, D. K. [2 ]
Prabhash, K. [1 ]
机构：
[1] Tata Mem Hosp, Tata Mem Ctr, Med Oncol Dept, Mumbai, Maharashtra, India
[2] Tata Mem Hosp, Tata Mem Ctr, Clin Res Secreteriat, Mumbai, Maharashtra, India
[3] Tata Mem Hosp, Med Oncol, Mumbai, Maharashtra, India
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.533
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
447P
引用
收藏
页码：S1637 / S1637
页数：1
相关论文
共 50 条
  • [1] Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Mutated Lung Cancer
    Noronha, Vanita
    Patil, Vijay Maruti
    Joshi, Amit
    Menon, Nandini
    Chougule, Anuradha
    Mahajan, Abhishek
    Janu, Amit
    Purandare, Nilendu
    Kumar, Rajiv
    More, Sucheta
    Goud, Supriya
    Kadam, Nandkumar
    Daware, Nilesh
    Bhattacharjee, Atanu
    Shah, Srushti
    Yadav, Akanksha
    Trivedi, Vaishakhi
    Behel, Vichitra
    Dutt, Amit
    Banavali, Shripad Dinanath
    Prabhash, Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (02) : 124 - +
  • [2] Phase III study of gefitinib or pemetrexed with carboplatin in EGFR-mutated advanced lung adenocarcinoma
    Patil, Vijay Maruti
    Noronha, Vanita
    Joshi, Amit
    Choughule, Anuradha Bharat
    Bhattacharjee, Atanu
    Kumar, Rajiv
    Goud, Supriya
    More, Sucheta
    Ramaswamy, Anant
    Karpe, Ashay
    Pande, Nikhil
    Chandrasekharan, Arun
    Goel, Alok
    Talreja, Vikas
    Mahajan, Abhishek
    Janu, Amit
    Purandare, Nilendu
    Prabhash, Kumar
    [J]. ESMO OPEN, 2017, 2 (01)
  • [3] Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer-Long-Term Results of a Randomized Clinical Trial
    Noronha, Vanita
    Patil, Vijay
    Menon, Nandini
    Shah, Minit
    Chougule, Anuradha
    Peelay, Zoya
    Prabhash, Kumar
    [J]. JAMA ONCOLOGY, 2024, 10 (06) : 743 - 744
  • [4] Gefitinib vs Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in EGFR-Variant Lung Cancer-Long-Term Results of a Randomized Clinical Trial
    Noronha, Vanita
    Patil, Vijay
    Menon, Nandini
    Shah, Minit
    Chougule, Anuradha
    Peelay, Zoya
    Prabhash, Kumar
    [J]. JAMA ONCOLOGY, 2024, 10 (06) : 824 - 826
  • [5] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Yuan, Ying
    Tan, Chunwen
    Li, Modan
    Shen, Hong
    Fang, Xuefeng
    Hu, Yinghong
    Ma, Shenglin
    [J]. WORLD JOURNAL OF SURGICAL ONCOLOGY, 2012, 10
  • [6] Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib
    Ying Yuan
    Chunwen Tan
    Modan Li
    Hong Shen
    Xuefeng Fang
    Yinghong Hu
    Shenglin Ma
    [J]. World Journal of Surgical Oncology, 10
  • [7] A Phase III Study Comparing Gefitinib and Inserted Cisplatin plus Pemetrexed with Gefitinib for EGFR-Mutated Advanced Non-Squamous NSCLC
    Kanda, Shintaro
    Mizutani, Tomonori
    Shibata, Taro
    Niho, Seiji
    Kurata, Takayasu
    Nakamura, Shinichiro
    Yamamoto, Nobuyuki
    Ohe, Yuichiro
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1085 - S1085
  • [8] Gefitinib and Pemetrexed Improve Survival in EGFR-Mutated NSCLC - Tarring all Patients With the Same Brush?
    Arulananda, Surein
    John, Thomas
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2020, 15 (01) : 12 - 14
  • [9] Phase III randomized trial comparing gefitinib to gefitinib with pemetrexed-carboplatin chemotherapy in patients with advanced untreated EGFR mutant non-small cell lung cancer (gef vs gef plus C).
    Noronha, Vanita
    Joshi, Amit
    Patil, Vijay Maruti
    Chougule, Anuradha
    Mahajan, Abhishek
    Janu, Amit
    Purandare, Nilendu
    Kumar, Rajiv
    More, Sucheta
    Goud, Supriya
    Kadam, Nandkumar
    Daware, Nilesh
    Shah, Srushti
    Yadav, Akanksha
    Dutt, Amit
    Trivedi, Vaishakhi
    Behel, Vichitra
    Banavali, Shripad Dinanath
    Prabhash, Kumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [10] Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
    Takahisa Kawamura
    Chiyo K. Imamura
    Hirotsugu Kenmotsu
    Tetsuhiko Taira
    Shota Omori
    Kazuhisa Nakashima
    Kazushige Wakuda
    Akira Ono
    Tateaki Naito
    Haruyasu Murakami
    Taisei Mushiroda
    Toshiaki Takahashi
    Yusuke Tanigawara
    [J]. Cancer Chemotherapy and Pharmacology, 2020, 85 : 605 - 614
12345